knowledge -WSS

knowledge

author：knowledge 2025-09-29 13:46:28 - browse：46233

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Doctor of U.S. President Joe Biden says he is fit for duty

focus

WSS

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Cholera vaccine supplies dangerously low, outbreaks surging

Cholera vaccine supplies dangerously low, outbreaks surging

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

5 ways to address the shortage of health care workers

SNAP should offer more nutrition education

focus

knowledge

entertainment

Medicare details structure of new drug price negotiation program

Are embryos people? Reproductive medicine's future depends on the answer

Virginia high school admissions case could be legal follow

SEC charges former device maker CEO with $41 million fraud

Virginia high school admissions case could be legal follow

Readout Newsletter: Beam, Prozac, "TechBio" and more

New air purifier tech could be key to improving indoor air quality

Ohio train derailment: Experts on toxic chemical risks

Virginia high school admissions case could be legal follow

Color Health wants to make cancer screenings convenient

leisure time

Color Health wants to make cancer screenings convenient

Can sheer will power keep patients alive in their dying hours?

Study fuels hope CAR

Children’s Hospital revives plan for pedestrian bridge

Medicare drug price negotiation hasn't dried up venture capital

'Vaccine

knowledge

focus

focus

entertainment